A New York-based health tech company leveraging the power of AI to create medically formulated food plans, RxDiet, has raised $3 million in seed funding to address poor diet, the leading cause of many chronic conditions.
Co-founded by Roman Kalista and Jan Skvaril, the company has received significant support in the seed round to expand its grocery network, strengthen its team, and extend services to diverse payers.
The round was spearheaded by Giant Ventures, with contributions from other investors such as Form Life and Better Ventures, alongside many angel investors including Immad Akhund from Mercury Bank.
RxDiet AI-powered Platform
RxDiet operates an innovative AI platform that formulates personalized food plans based on individual taste preferences and medical needs. These plans are delivered directly to patients with chronic illnesses like hypertension and diabetes.
The company’s patient-specific food plans align with its Food as Medicine mission, which seeks to drive down healthcare costs and improve care outcomes using cost-effective AI-driven meal plans.
So far, RxDiet has partnered with two of the three leading health insurers in the United States, enabling their plans to cover the program cost. It also partners with national grocery stores to provide locally sourced food ingredients, allowing the patients to prepare their own medically tailored meals.
By addressing poor diet, which is often the cause of many chronic illnesses, the platform provides a holistic solution that helps to manage, reverse, or prevent such chronic conditions. The tailored meal plans are cost-effective, personalized, and engaging to all patients under the program.
According to the company’s co-founders, the seed investment will help RxDiet scale its services and reach more people across the United States.